About Finecure pharma
Finecure pharma is a Healthcare company based in Ahmedabad (India) founded in 2005. Manufacturer of pharmaceutical formulations for various therapeutic areas. Finecure pharma has raised $131.47 thousand across 1 funding round from investors including Vikas Agrawal, Ramavtar Prasad and Rupa Agrawal. The company has 454 employees. Finecure pharma was last valued at $444.13 thousand in March 2007. Its chief executive, as recorded, is Vishal Rajgarhia. Its Indian entity Finecure Pharmaceuticals Limited reported revenue of ₹202 Cr. Finecure pharma offers products and services including Antibiotics and Anti-Infectives and Anti-Asthmatics and Anti-Allergic Drugs. Its focus areas include Traditional Pharmaceuticals and Diversified.
Company details
Founded in 2005 in Ahmedabad, India, operations are focused on the pharmaceutical sector, where formulations in oral dosage forms and injections are produced for niche therapeutic segments including cardiovascular, diabetology, neurology, and anti-infectives. Certifications such as WHO-GMP are held by manufacturing plants. A dedicated division is maintained for innovative medicines targeting cardiovascular and diabetology treatments, with products extending to gastrointestinal, dermatology, pain management, and OTC areas.
- Headquarters Ahmedabad, India
- Employees 454
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website finecurepharma.com
- Social LinkedIn X Facebook
- Legal Name Finecure Pharmaceuticals Limited
- Date of Incorporation 18 Mar, 2005
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹202 Cr
FY 2025 · -9% YoY
- Net Loss-₹9.90 Cr
FY 2025 · -5% margin
- EBITDA₹4.06 Cr
FY 2025 · 2% margin
- Total Equity Funding$131.47K (USD)
in 1 rounds
- Latest Funding Round$131.47K (USD), Seed
Mar 2007
- Investorsmihiragencies
& 20 more
- Employee Count454
Associated legal entities of Finecure pharma
Finecure pharma operates through Finecure Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Finecure Pharmaceuticals Limited CIN U24230GJ2005PLC045724 | Active | 18 Mar 2005 | Ahmedabad, Gujarat | ₹202 Cr | 454 | 8 | View details |
Products & Services of Finecure pharma
Finecure pharma offers a comprehensive portfolio of products and services, including Antibiotics and Anti-Infectives and Anti-Asthmatics and Anti-Allergic Drugs.
Products are provided for treating infections, including antibiotics and antimalarials that act selectively on disease causes
Drugs are designed for addressing respiratory diseases such as asthma and allergic rhinitis
Funding Insights of Finecure pharma
Finecure pharma has successfully raised a total of $131.47K through 1 strategic funding round. The most recent funding activity was a Seed round of $131.47 thousand completed in March 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $131,474
- Total Rounds 1
- Last Round Seed — $131,474
- First Round $131,474
(Mar 2007)
- Investors Count 21
All 1 funding rounds of Finecure pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2007 | $131,474 | Seed | $444,128 | – |
Last known valuation $444,128 (Mar 2007). 21 investors in total: 2 institutional and 19 angel.
Investors in Finecure pharma
Finecure pharma has secured backing from 21 investors, including angel and institutional investors. Prominent investors backing the company include Vikas Agrawal, Ramavtar Prasad and Rupa Agrawal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| mihiragencies.tcc.mode | ||||
VA Vikas Agrawal | Angel investor, ex-entrepreneur, focused on tech startups in India. | unknown_30a1dad001254b76a | ||
RP Ramavtar Prasad | unknown_6407a04678104c43a | |||
RA Rupa Agrawal | unknown_949709425c9d423da | |||
S Satyabhamadevi | unknown_523c90e4c3cc4e66b | |||
NA Nidhi Agrawal | Co-founder of KAARYAH, angel investor in Indian startups | unknown_b01062c53cd446daa | ||
VK Vinod Kumar Sharma | unknown_b1d10a61d34148648 | |||
PM Pannalal Maheshwari | unknown_75ac618865214fa58 | |||
SS Suresh Shah | unknown_9ad5fb5c712346c79 | |||
DJ Deepali Jshah | unknown_bc4d4491e95d4126a |
Investor details for Finecure pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Finecure Pharmaceuticals Limited (Finecure pharma)
Finecure Pharmaceuticals Limited is the primary company behind Finecure pharma. The board of Finecure Pharmaceuticals Limited currently have 6 directors; the longest-serving is Vivek Rajgarhia, appointed in 2005. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vivek Rajgarhia DIN 00225406 | Whole-time director | 18 Mar 2005 | 21 yrs 7 mo | Finecure Pharmaceuticals Limited |
| Vishal Haremurari Rajgarhia DIN 00225415 | Whole-time director | 18 Mar 2005 | 21 yrs 7 mo | Finecure Pharmaceuticals Limited |
| Vikash Rajgarhia DIN 00225426 | Managing Director | 18 Mar 2005 | 21 yrs 7 mo | Finecure Pharmaceuticals Limited |
| Anshu Krishnakumar Agrawal DIN 07931194 | Director | 21 Dec 2017 | 8 yrs 10 mo | Finecure Pharmaceuticals Limited |
| Mukesh Tarachand Agarwal DIN 00118813 | Director | 21 Dec 2017 | 8 yrs 10 mo | Finecure Pharmaceuticals Limited |
| Niraj Kumar Harodia DIN 06676837 | Director | 28 Jan 2025 | 1 yr 9 mo | Finecure Pharmaceuticals Limited |
People of Finecure pharma
1 people are tracked at Finecure pharma (1 in leadership); the tracked headcount is 454.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for Finecure pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Finecure pharma
Figures of Finecure Pharmaceuticals Limited, the primary company behind Finecure pharma, for FY 2025. Revenue was ₹202 Cr (-9% year on year). Net loss was -₹9.90 Cr (-5% margin). EBITDA was ₹4.06 Cr (2% margin). Revenue has grown at a compounded annual rate of +8% over three years and +9% over five years.
- ₹202 CrRevenue · FY 2025 · -9% YoY
- -₹9.90 CrNet loss · -5% margin
- ₹4.06 CrEBITDA · 2% margin
- ₹12.71 CrPaid-up capital
- 454Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Finecure Pharmaceuticals Limited are on its company page.
Detailed financial statements for Finecure pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Finecure pharma
2 dated milestones of Finecure pharma across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Finecure pharma is founded.
- Funding First funding round of $131K.
Web traffic of Finecure pharma
The website of Finecure pharma (finecurepharma.com) receives about 2.2K visits a month and ranks #5,631,169 among all websites worldwide, #6,176 in Biotechnology and Pharmaceuticals.
- Monthly visits2.2K
▼ 23.4% vs previous month
- Unique visitors1.4K
per month
- Global rank#5,631,169
among all websites
- Category rank#6,176
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.7
- Average visit31 sec
- DevicesDesktop 48% · Mobile 52%
Websites whose visitors overlap most with Finecure pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| belcoindia.com | 100% | #2,738,256 | View details | ||
jpm.com.jo | jpm.com.jo | 100% | #6,722,301 | – | |
| sentisspharma.com | 95% | 10.3K | #1,920,442 | View details | |
| cooperpharma.com | 94% | 17.9K | #1,398,892 | View details | |
| swisspharma.in | 93% | 1.3K | #10,147,211 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Finecure pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Finecure pharma (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Finecure pharma
Finecure pharma was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Finecure pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Vishal Rajgarhia is the CEO of Finecure pharma, as recorded in our data.
Finecure pharma is a funded company, having raised a total of $131.47K across 1 funding round to date. The company's 1st funding round was a Seed of $131.47K, raised on Mar 2007.
Finecure pharma has 454 employees.
The primary company behind Finecure pharma, Finecure Pharmaceuticals Limited, reported revenue of ₹202 Cr for FY 2025, down 9% year on year.
Founded in 2005 in Ahmedabad, India, operations are focused on the pharmaceutical sector, where formulations in oral dosage forms and injections are produced for niche therapeutic segments including cardiovascular, diabetology, neurology, and anti-infectives. Certifications such as WHO-GMP are held by manufacturing plants. A dedicated division is maintained for innovative medicines targeting cardiovascular and diabetology treatments, with products extending to gastrointestinal, dermatology, pain management, and OTC areas.
Finecure pharma offers Antibiotics and Anti-Infectives and Anti-Asthmatics and Anti-Allergic Drugs.
Finecure pharma has 21 investors. Key investors include Vikas Agrawal, Ramavtar Prasad, Rupa Agrawal, Satyabhamadevi, and mihiragencies.
The valuation of Finecure pharma is $444.13K as of Mar 2007.
Finecure pharma operates through Finecure Pharmaceuticals Limited.
The legal entities of Finecure pharma currently have 8 directors, including Vivek Rajgarhia, Vishal Haremurari Rajgarhia, Vikash Rajgarhia and others.